Group of Molecular Epidemiology & Cancer Precision Prevention (GMECPP), Institute of Occupational Diseases, Zhejiang Academy of Medical Sciences (ZJAMS), Hangzhou, China.
Department of Preventive Medicine, Ningbo University Medical School, Ningbo, China.
J Gynecol Oncol. 2018 Jan;29(1):e7. doi: 10.3802/jgo.2018.29.e7.
Cancer has become a major disease burden across the globe. It was estimated that 4.29 million new incident cases and 2.81 million death cases of cancer would occur in 2015 in China, with the age-standardized incidence rate (ASIR) of 201.1 per 100,000 and age-standardized mortality rate (ASMR) of 126.9 per 100,000, respectively. For females, 2 of the top 10 most common types of cancer would be gynecologic cancers, with breast cancer being the most prevalent (268.6 thousand new incident cases) and cervical cancer being the 7th most common cancer (98.9 thousand new incident cases). The incidence and mortality of gynecologic cancers have been constantly increasing in China over last 2 decades, which become a major health concern for women. Survival rates of gynecologic cancers are generally not satisfactory and decrease along with advancing stage, though national data on survival are still not available. It is of great importance to overview on the epidemiology of gynecologic cancers, which may provide scientific clues for strategy-making of prevention and control, and eventually lowering the incidence and mortality rate as well as improving the survival rate in the future.
癌症已经成为全球范围内的主要疾病负担。据估计，2015 年中国将有 429 万例新发病例和 281 万例癌症死亡病例，年龄标准化发病率（ASIR）为 201.1/10 万，年龄标准化死亡率（ASMR）为 126.9/10 万。对于女性来说，前 10 种最常见的癌症中有 2 种是妇科癌症，其中乳腺癌最为常见（新发病例 26.86 万例），宫颈癌是第 7 常见癌症（新发病例 9.89 万例）。过去 20 年来，中国妇科癌症的发病率和死亡率一直在不断上升，这成为女性健康的主要关注点。尽管全国范围内仍缺乏关于生存率的具体数据，但妇科癌症的生存率通常并不理想，且随着疾病分期的进展而下降。因此，全面了解妇科癌症的流行病学情况十分重要，这可能为制定预防和控制策略提供科学线索，并最终降低未来的发病率、死亡率和提高生存率。
